Gonorrhea Figures
 
This web page is archived for historical purposes and is no longer being updated. Newer data is available on the STD Data and Statistics page.
 
 Figure 13. Gonorrhea — Rates: United States, 1941–2008
 Figure 13. Gonorrhea — Rates: United States, 1941–2008
 Figure 14. Gonorrhea — Rates: Total and by sex: United States, 1989–2008
 Figure 14. Gonorrhea — Rates: Total and by sex: United States, 1989–2008
 Figure 15. Gonorrhea — Rates by region: United States, 1999–2008
 Figure 15. Gonorrhea — Rates by region: United States, 1999–2008
 Figure 16. Gonorrhea — Rates by state: United States and outlying areas, 2008
 Figure 16. Gonorrhea — Rates by state: United States and outlying areas, 2008
 Figure 17. Gonorrhea — Rates by county: United States, 2008
 Figure 17. Gonorrhea — Rates by county: United States, 2008
 Figure 18. Gonorrhea — Age- and sex-specific rates: United States, 2008
 Figure 18. Gonorrhea — Age- and sex-specific rates: United States, 2008
 Figure 20. Gonorrhea — Age-specific rates among men 15 to 44 years of age: United States, 1999–2008
 Figure 20. Gonorrhea — Age-specific rates among men 15 to 44 years of age: United States, 1999–2008
 Figure 21. Gonorrhea — Rates by race/ethnicity: United States, 1999–2008
 Figure 21. Gonorrhea — Rates by race/ethnicity: United States, 1999–2008
 Figure 22. Gonorrhea — Cases by reporting source and sex: United States, 1999–2008
 Figure 22. Gonorrhea — Cases by reporting source and sex: United States, 1999–2008
 Figure 26. Distribution of MICs to azithromycin among GISP isolates, 2004–2008
 Figure 26. Distribution of MICs to azithromycin among GISP isolates, 2004–2008
- Page last reviewed: November 16, 2009 (archived document)
- Content source:
 ShareCompartir
ShareCompartir
 Figure 19. Gonorrhea — Age-specific rates among women 15 to 44 years of age: United States, 1999–2008
 Figure 19. Gonorrhea — Age-specific rates among women 15 to 44 years of age: United States, 1999–2008 Figure 23. Gonorrhea — Positivity among 15- to 24-year-old women tested in family planning clinics by state: United States and outlying areas, 2008
 Figure 23. Gonorrhea — Positivity among 15- to 24-year-old women tested in family planning clinics by state: United States and outlying areas, 2008 Figure 24. Location of participating sentinel sites and regional laboratories in the United States, 2008
 Figure 24. Location of participating sentinel sites and regional laboratories in the United States, 2008 Figure 25. Gonococcal Isolate Surveillance Project (GISP) — Distribution of MICs to ceftriaxone among GISP isolates, 2004–2008
 Figure 25. Gonococcal Isolate Surveillance Project (GISP) — Distribution of MICs to ceftriaxone among GISP isolates, 2004–2008 Figure 27. Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance or intermediate resistance to ciprofloxacin, 1990–2008
 Figure 27. Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance or intermediate resistance to ciprofloxacin, 1990–2008 Figure 28. Gonococcal Isolate Surveillance Project (GISP) — Penicillin, tetracycline, and ciprofloxacin resistance among GISP isolates, 2008
Figure 28. Gonococcal Isolate Surveillance Project (GISP) — Penicillin, tetracycline, and ciprofloxacin resistance among GISP isolates, 2008 Figure 29. Gonococcal Isolate Surveillance Project (GISP) — Drugs used to treat gonorrhea in GISP patients, 1988–2008
Figure 29. Gonococcal Isolate Surveillance Project (GISP) — Drugs used to treat gonorrhea in GISP patients, 1988–2008